Carocare Wellness review

Carocare advertises Houston and surrounding areas, publishes its Harwin Drive address and offers a free consultation. Its public pages leave NAD⁺ price, treatment terms and staff identity unresolved. Telehealth and national NAD⁺ shipping are not established, and injected NAD⁺ has no controlled human outcome trials behind it.

Carocare Wellness describes a medically guided clinic serving Houston and surrounding areas, with NAD⁺ injections, separate IV hydration services, GLP-1 care, routine/sick visits, annual wellness blood work and hair-growth gummies. A free consultation is linked through Calendly. Caroline/NP Caroline appears in third-party testimonial text, not a first-party staff biography; that does not verify a clinician, credential or operator. NAD⁺ injections are listed, but exact route, ingredients, concentration and quantity are not established. Separate IV hydration services do not establish a NAD⁺ IV offering.

The clinic publishes a Houston address and direct contact options. Public pages do not establish telehealth eligibility or a national NAD⁺ shipping program; that absence is not a prohibition on every nonlocal patient. Obtain the visit arrangement before booking. A first-party named clinician biography, treating legal entity and dispensing pharmacy are not established. GLP-1 packages advertise support, supplies and delivery, but those inclusions do not establish NAD⁺ terms. NAD⁺ lab requirements, age minimum, insurance/HSA/FSA rules and consultation or medication charges beyond the free consultation offer remain unclear. An annual exam accessible without insurance does not determine NAD⁺ coverage.

No NAD⁺ price is listed on the public pages. Ask for the full charge, whether billing is per injection, vial or course, the prescribed quantity and supply, and any lab or follow-up costs. NAD⁺ renewal, cancellation, refunds and shipping terms are not established. The free consultation offer does not settle those charges.

The separate GLP-1 schedule lists semaglutide at $180/$210/$240/$270/$300/$330 for months 1–6, with $500 and $600 three-month bundles for months 1–3 and 4–6. Tirzepatide lists $200/$250/$280/$300/$325/$350, with $600 and $800 bundles. Support, supplies and delivery are advertised for those packages only. Neither their amounts nor their structure establish a NAD⁺ price, supply or inclusion.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. NAD⁺ for injection is a compounding-pharmacy preparation, not an FDA-approved product, and Carocare does not name the pharmacy that prepares it. The FDA does not review compounded sterile products for purity and potency the way it reviews approved drugs, which is why an unnamed pharmacy is a real question rather than a paperwork one. On the evidence, the clinic's own framing is worth pushing back on. Injected NAD⁺ has no controlled human outcome trials supporting the energy, cognition or healthy-aging claims the category is sold on; the single human intravenous study was a pharmacokinetic pilot that found infused NAD⁺ clears from plasma quickly. The comparison with oral supplements is the wrong axis: the NAD⁺ forms with human trial data are the oral precursors NR and NMN, and what those trials show is a rise in blood NAD⁺, a biomarker rather than a demonstrated clinical benefit. Better absorption of something without outcome data does not produce outcome data. Individual results vary.